Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1097 - 1104 of 11439 results
Washington Energy & Sustainability Update — May 2023
May 2, 2023| Blog| Viewpoint
Senate HELP Committee Eyes Drug Pricing and PBM Regulation Beyond Federal Programs
May 2, 2023| Blog| Viewpoint
What’s New in Wireless - May 2023
May 2, 2023| Blog| Viewpoint
Are You Ready? How to Prepare for the End of OCR’s Public Health Emergency HIPAA Enforcement Discretion
May 1, 2023| Blog| Viewpoint
Legaltech Startup, Clara Enters US market In Partnership With Mintz
May 1, 2023| News
Legal Tech Co. Clara Enters US Market With Mintz Deal
May 1, 2023| News
Telephone and Texting Compliance News — April 2023
April 28, 2023| Article| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.